Skip to content

Research paper

Effect of Supplementation With High-Selenium Yeast on Plasma Lipids

Annals of Internal Medicine
Q1
May 2011
Citations: 95
Influential: 1
Interventional (Human) Studies
82

Study answer

What this study found

Selenium supplementation produced modest, dose-specific improvements in plasma lipids, but the pattern was not uniform and the clinical significance is uncertain. In the 100 mcg/day arm, total cholesterol fell more than placebo by -0.22 mmol/L (95% CI -0.42 to -0.03; P=0.02) and non-HDL cholesterol by -0.20 mmol/L (95% CI -0.37 to -0.04; P=0.02). In the 200 mcg/day arm, total cholesterol decreased by -0.25 mmol/L (95% CI -0.44 to -0.07; P=0.008), non-HDL cholesterol by -0.27 mmol/L (95% CI -0.43 to -0.10; P=0.001), and the total-HDL cholesterol ratio by -0.15 (95% CI -0.26 to -0.03; P=0.02).…

Study & population
Randomized, placebo-controlled trial in older adults in the United Kingdom with relatively low selenium status.
Intervention
Participants received high-selenium yeast (SelenoPrecise, Pharma Nord) or placebo yeast once daily for 6 months.
Key limitation
Effects were modest, dose-specific, and not consistent across all lipid outcomes or selenium doses.
View sourceOpen PDF

Original abstract

BACKGROUND High selenium status has been linked to elevated blood cholesterol levels in cross-sectional studies. OBJECTIVE To investigate the effect of selenium supplementation on plasma lipids. DESIGN Randomized, placebo-controlled, parallel-group s…